<--- Back to Details
First PageDocument Content
Skin cancer / BRAF / Cancer / Metastasis / Immunotherapy / Uveal melanoma / DecisionDx-UM / Medicine / Melanoma / Vemurafenib
Date: 2013-05-29 02:40:11
Skin cancer
BRAF
Cancer
Metastasis
Immunotherapy
Uveal melanoma
DecisionDx-UM
Medicine
Melanoma
Vemurafenib

Microsoft Word - mMelanoma Disease Backgrounder May2013

Add to Reading List

Source URL: www.roche.com

Download Document from Source Website

File Size: 100,46 KB

Share Document on Facebook

Similar Documents

Chemistry / Clinical medicine / Organic chemistry / MEK inhibitor / Protein kinase inhibitors / B-Raf inhibitor / Sulfonamides / Vemurafenib / Cobimetinib / Keratoacanthoma / Ofloxacin

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COTELLIC safely and effectively. See full prescribing information for COTELLIC. COTELLIC (cobimetinib) tablets, for

DocID: 1pQS7 - View Document

Prostate cancer / Abiraterone / Melanoma / Docetaxel / Vemurafenib / Metastasis / Eastern Cooperative Oncology Group / Medicine / Chemistry / Organofluorides

SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Vemurafenib, Abiraterone, Enzalutamide) Part 1 - Patient Information

DocID: 1gjh0 - View Document

Sulfonamides / Vemurafenib / Medicine / Chemistry / BRAF / Biology / Melanoma / Organochlorides / Organofluorides

Machine Reading for Cancer Panomics Hoifung Poon 1

DocID: 1fQeq - View Document

490 NEDERLANDS TIJDSCHRIFT VOOR DERMATOLOGIE EN VENEREOLOGIE | VOLUME 23 | NUMMER 08 | september 2013 Spiny folliculaire hyperkeratose door vemurafenib, een BRAF‑remmer

DocID: 1epqH - View Document

Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent

DocID: 1bnwn - View Document